iCAD Announces Estimated Q1 Revenue and Upcoming Board and CFO Transitions
Company expects preliminary estimated revenue to be $7.5 million Timothy Norris Irish appointed Chairman of the Board of Directors, successor...
Month: April 2022
Impel NeuroPharma to Ring Nasdaq Closing Bell on Monday, April 25
Impel Celebrates Its One-Year Anniversary as a Public CompanySEATTLE, April 21, 2022 (GLOBE NEWSWIRE) -- Impel NeuroPharma (NASDAQ: IMPL), a...
DLH to Announce Second Quarter FY22 Financial Results
ATLANTA, April 21, 2022 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and...
Accelus Announces First Procedure Integrating Remi Robotic Navigation System, LineSider Spinal System, and FlareHawk Expandable Interbody Fusion Device Technologies
Tien V. Le, M.D., recently performed the first procedure integrating the Remi Robotic Navigation System, LineSider Spinal System, and FlareHawk...
Simply Better Brands Corp and Jones Soda Co. Sign Binding LOI With Merger Leading to Accelerated Scale and Momentum in High Growth Categories
Business combination intended to enable accelerated growth in plant-based wellness, food and beverage and health and beauty growth marketsFull Year...
Aileron Expands Management Team with Appointment of Christopher Zergebel As Vice President, Program Management and Clinical Operations
Mr. Zergebel brings over 20 years of industry experience, primarily focused in oncology, and broad expertise to help Aileron ensure...
Sotera Health Announces First-Quarter 2022 Earnings Release Date
CLEVELAND, April 21, 2022 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization...
Intra-Cellular Therapies Announces Appointment of E. Rene Salas to Board of Directors
NEW YORK, April 21, 2022 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and...
Codexis and seqWell Announce Strategic Investment and Partnership Initiation
seqWell raises $7M Series C funding, led by CodexisCurrent investors Research Corporation Technologies and BroadOak Capital Partners also participated in...
MS Million Dollar Tower Challenge Aims to Raise $4m for MS Research by Sending More Than 140 Donors Rappelling Off Toronto Office Tower
Photo of 700 University Avenue, Toronto Photo of 700 University Avenue, TorontoTORONTO, April 21, 2022 (GLOBE NEWSWIRE) -- The Multiple...
Todos Medical Appoints Philippe Goix as Chief Commercial Officer for Provista Diagnostics
Strengthens Management Team and Positions the Company for Growth and Expansion New York, NY, and Tel Aviv, ISRAEL, April 21,...
Arbutus to Report First Quarter 2022 Financial Results and Provide Corporate Update
WARMINSTER, Pa., April 21, 2022 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive...
Alignment Healthcare to Announce First Quarter 2022 Financial Results and Host Conference Call Thursday, May 5, 2022
ORANGE, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (Nasdaq: ALHC), a tech-enabled...
InMed Commercializes Cannabidivarin (CBDV), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector
Expands rare cannabinoid portfolio beyond current CBC and CBTReleases White Paper outlining research into the therapeutic potential of CBDVVANCOUVER, British...
Chalice Brands Ltd. Announces Execution of Definitive Agreements to Acquire Oregon Retail Stores and Cultivation Assets
PORTLAND, Ore., April 21, 2022 (GLOBE NEWSWIRE) -- Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) (“Chalice” or the “Company”), a...
OncXerna Therapeutics Announces Journal of Clinical Oncology Publication Featuring Phase 1b Data of Navicixizumab Plus Paclitaxel in Ovarian Cancer
Overall response rate (ORR) of 43% and median duration of response of 6 months seen with navicixizumab-paclitaxel combination in heavily...
Brooklyn ImmunoTherapeutics Announces Establishment of New Research and Development Facility for Advancement of Engineered Cellular Medicines
Company has expanded team with scientific hires who hold research expertise in stem cells, synthetic RNA, nanoparticle delivery systems and...
VectivBio Appoints Patrick Malloy as Senior Vice President, Investor Relations & Strategic Communications
Arena Pharmaceuticals and Actelion veteran brings deep industry experience as VectivBio prepares for key upcoming catalystsBASEL, Switzerland, April 21, 2022 (GLOBE...
CareDx Supports UC Davis Health Pluralist Program Aimed at Reducing Health Disparities in Organ Transplantation
SOUTH SAN FRANCISCO, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on...
The Joint Corp. to Host Conference Call on Thursday, May 5th to Discuss First Quarter 2022 Results
SCOTTSDALE, Ariz., April 21, 2022 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care...
